Other research shows treatment leads to high patient satisfaction
Swallowing pills containing a concentrate of fecal bacteria successfully stops recurrent bouts of debilitating Clostridium difficile (C. diff) infection by rebalancing the bacteria in the gut, suggests a study being presented at the IDWeek 2013™ meeting today.
Infection from C. diff bacteria is such a concern that the Centers for Disease Control and Prevention (CDC) named it one of the three most urgent threats in its recent landmark report on antibiotic resistance. C. diff sickens half a million Americans and kills 14,000 every year. C. diff infection can occur after people take antibiotics, wiping out the good bacteria in the gastrointestinal (GI) system, allowing C. diff to flourish and leading to severe diarrhea. In some patients, infection continues to recur despite standard treatment with antibiotics. For patients trapped in that cycle, doctors have transplanted feces from healthy donors into their GI system to rebalance the bacteria and stop infections from recurring.
Fecal transplantation typically is delivered by enema, colonoscopy (placing a tube in the colon) or nose tube and is effective in nine out of 10 patients, according to published reports. The IDWeek research suggests the less-invasive pills are a viable and effective delivery method.
“Recurrent C. diff infection is such a miserable experience and patients are so distraught that many ask for fecal transplantation because they’ve heard of its success,” said Thomas Louie, MD, professor of medicine at the University of Calgary, Alberta, and lead author of the pill study. “Many people might find the idea of fecal transplantation off-putting, but those with recurrent infection are thankful to have a treatment that works.”
Indeed, additional research being presented at the meeting showed patients who received fecal transplantation through a tube in the nose were highly satisfied with the treatment, and said they would likely recommend it to a friend.
Fecal Transplantation by Pill
University of Calgary researchers reported a 100 percent success rate – none of the 27 patients who took the tablet-sized pills had a recurrence of C. diff, even though all of them previously had had at least four bouts of the infection. Patients ingested between 24 and 34 capsules containing fecal bacteria, often donated by family members.
To make the pills, researchers processed the feces until it contained only bacteria, and then encapsulated the bacterial concentrate inside three layers of gelatin capsule. This ensured the pills wouldn’t leak or disintegrate until they were past the stomach and into the small intestine – a potential advantage over other methods because it covers more of the GI tract, does not involve invasive and more costly procedures, and is more comfortable for patients, Dr. Louie said.
Dr. Louie said he first made pills for fecal transplantation when one patient failed to respond to the enema method on two occasions and also could not tolerate a nasal tube for medical reasons. The pills are made individually.
“The pills are a one-shot deal and seem to work. They are easier for patients and are well-tolerated,” said Dr. Louie. “It’s an exciting development in the field and could possibly even be used to maintain the balance of bacteria in the GI system in patients at risk for C. diff.””
Patient Satisfaction of Fecal Transplantation
In the study of fecal transplantation tolerance, researchers surveyed 28 patients three months after they had undergone the treatment through a tube fed through the nose and GI system to the small intestine. On a scale of one to 10, average patient scores were: 9.6 for overall satisfaction; 9.9 for ease; and 9.9 for likelihood of recommending the procedure to a family member or friend.
“Patients with C. diff often have 20 or more stools a day, which seriously affects quality of life and so they are very open to this treatment,” said Ravi Kamepalli, MD, an infectious diseases physician at the Regional Infectious Disease-Infusion Center, Lima, Ohio, and lead author of the study. “Human beings are 90 percent bacteria and once that balance is altered with antibiotics, opportunistic infections can cause serious problems. All we are doing with this treatment is resetting the balance.”
The Latest Bing News on:
- Clostridium Difficile Infection Treatment Market Product Portfolio by Leading Players (2022-2031): Merck and Baxter Internationalon February 28, 2021 at 10:48 pm
A recent systematic review report on “Clostridium Difficile Infection Treatment Market Insights with Statistics ...
- C. difficile outbreak at Cowichan Hospital contained to one wingon February 22, 2021 at 6:00 pm
In addition to concerns about the ongoing COVID-19 pandemic, the Cowichan District Hospital has been dealing with an outbreak of Clostridium difficile — better known as C. difficile — throughout ...
- Vitamins & Supplements Centeron February 19, 2021 at 11:33 am
Considering taking a vitamin or supplement to treat Clostridium+Difficile Infection? Below is a list of common natural remedies used to treat or reduce the symptoms of Clostridium+Difficile Infection.
- US Clostridium Difficile Diagnostics and Treatment…on February 19, 2021 at 2:00 am
Pune, Maharashtra, India, February 19 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Clostridium Difficile Diagnostics and Treatment Market is valued around USD 1362.99 ...
- C. Difficile: Clinical Practice Guidelines and Treatment Optionson February 12, 2021 at 6:28 am
Peter L. Salgo, MD: Let’s focus for a minute on some practice guidelines—you did mention guidelines—specifically for treating recurrent episodes of CDI [Clostridium difficile infection]. There are the ...
- Outbreak of “Clostridium Difficile” in Uruguay's largest hospital; situation under controlon February 10, 2021 at 4:00 pm
Uruguay's main university hospital, suffering from an outbreak of the highly contagious bacteria “Clostridium Difficile” has been recommended “to suspend new entries to the sections involved ...
- Clostridium Difficile News and Researchon February 9, 2021 at 4:01 pm
Could number two be number one when it comes to combating recurrent Clostridium difficile (CDI) infections?Using genetic material analysis and machine learning, UBC researchers have pinpointed ...
- Clostridium Difficile Diagnostics and Treatment Marketon February 7, 2021 at 7:48 pm
This Global Clostridium Difficile Diagnostics and Treatment Market report has been formulated by considering an ever-increasing demand and the value of market research for the success of different ...
- Clostridium Difficile Infection Treatment Market Analysis and Forecast 2020: By Acumen Research and Consultingon February 5, 2021 at 3:46 am
pune, India, Fri, 05 Feb 2021 06:37:47 / Comserve Inc. / -- The global clostridium difficile infection treatment market is anticipated to grow at a CAGR of around 5.8% during the forecast period ...
- Modulating gut microbiota to treat canceron February 4, 2021 at 12:11 pm
In 1958, fecal microbiota transplantation (FMT) was reported as a treatment for Clostridium difficile infection that was resistant to antibiotics (2). FMT became an option for routine treatment for ...
The Latest Google Headlines on:
The Latest Bing News on:
- A WHAT transplant? It’s true — No. 2 can be No. 1 at saving liveson March 2, 2021 at 6:46 am
According to Brandt, poop transplants are serious business and have saved thousands of lives in the U.S. and worldwide. It is actually the microorganisms within the poop (also known as “feces” or ...
- Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patientson March 2, 2021 at 5:47 am
Measurement(s) gut microbiome measurement • Cell Density • Clinical Data Technology Type(s) DNA sequencing • quantitative PCR • clinical laboratory measurement • 16s ribosomal gene sequencing assay Fa ...
- ‘Gory Details’ dives into the morbid, the taboo — and our mindson March 1, 2021 at 2:00 am
But just because something is disgusting, morbid or taboo shouldn’t keep us from learning about it — and could even be a cue that we should, posits science journalist. In Gory Details, Engelhaupt ...
- Giorgio Trinchieri, MD, on Fecal Microbiota Transplant to Promote Immunotherapy Responseon February 26, 2021 at 5:00 am
Giorgio Trinchieri, MD, of the National Cancer Institute’s Center for Cancer Research joined CancerNetwork® to discuss enhancing the gut microbiome by way of fecal transplant for better immunotherapy ...
- Fecal Transplant May Counter Anti-PD-1 Resistance in Melanomaon February 24, 2021 at 4:43 am
Fecal microbiota transplantation (FMT) together with anti-programmed cell death protein 1 (PD-1) therapy possibly may alter the gut microbiome and overcome resistance to anti-PD-1 in some patients ...
- OpenBiome to wind down stool bank operationson February 23, 2021 at 1:03 pm
OpenBiome will soon end its program for collecting, screening, and shipping material for fecal microbiota transplants, or FMT.
- High engraftment capacity of frozen ready-to-use human fecal microbiota transplants assessed in germ-free miceon February 23, 2021 at 4:03 am
The number of indications for fecal microbiota transplantation is expected to rise, thus increasing the needs for production of readily available frozen or freeze-dried transplants. Using shotgun ...
- Pooping Out Miracles: Successful Mechanism Behind Fecal Microbiota Transplantation Revealedon February 22, 2021 at 2:43 pm
Osaka City University demonstrates success of fecal microbiota transplantation (FMT) by revealing the coordinated effort of bacteriophages (phages) and their host bacteria in restoring human ...
- Penn Scientists Discover Microbial Transplants Require Key T Cells for Successon February 20, 2021 at 4:15 pm
PHILADELPHIA: Scientists have known for more than a decade that “good bacteria” from healthy intestines can treat and ward off potentially deadly intestinal infections by Clostridium difficile ...
- Fecal Transplants Might Help Boost Cancer Treatment, Study Findson February 4, 2021 at 6:01 am
Fecal transplants, already being studied as a treatment for colon infections and type 2 diabetes, may also help the body fight cancer, new U.S. government-funded research suggests. In a small ...